Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹17Cr
Rev Gr TTM
Revenue Growth TTM
-30.97%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

SRECR
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | -76.0 | -81.0 | -62.9 | 122.7 | 139.7 | 18.2 | 3.8 | -51.2 | -50.6 | 0.0 | -22.6 | -29.7 |
| 8 | 8 | 8 | 17 | 16 | 8 | 9 | 10 | 8 | 9 | 7 | 7 |
Operating Profit Operating ProfitCr |
| -13.8 | -5.6 | 1.1 | 12.3 | 11.1 | 2.8 | -4.6 | -1.3 | 4.8 | 0.5 | -6.3 | -6.1 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| -1 | -1 | 0 | 2 | 2 | 0 | -1 | 0 | 0 | 0 | -1 | -1 |
| 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | -176.9 | -123.3 | -126.9 | 576.1 | 151.9 | 109.8 | -700.0 | -115.1 | -34.9 | -316.7 | -1.8 | -66.7 |
| -21.5 | -8.4 | -0.9 | 11.1 | 4.7 | 0.7 | -6.6 | -3.4 | 6.1 | -1.5 | -8.7 | -8.2 |
| -4.0 | -1.5 | -0.2 | 5.5 | 2.1 | 0.2 | -1.2 | -0.7 | 1.3 | -0.3 | -1.3 | -1.3 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| 1.9 | -21.9 | 2.2 | 13.3 | 16.3 | -9.7 | 16.0 | 110.4 | 5.5 | -30.8 | -33.0 | -13.4 |
| 30 | 24 | 25 | 28 | 32 | 29 | 32 | 67 | 74 | 49 | 35 | 31 |
Operating Profit Operating ProfitCr |
| 3.1 | 0.5 | 0.9 | 0.9 | 1.3 | 3.0 | 8.6 | 7.0 | 2.8 | 7.7 | 0.5 | -1.2 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| 0 | 0 | 0 | -1 | 0 | 0 | 2 | 4 | 1 | 3 | -1 | -1 |
| 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 0 |
|
| 170.2 | -229.3 | 14.8 | -103.3 | 81.3 | 357.0 | 625.3 | 67.2 | -73.7 | 188.1 | -115.7 | -92.4 |
| 0.8 | -1.3 | -1.1 | -1.9 | -0.3 | 0.9 | 5.4 | 4.3 | 1.1 | 4.4 | -1.0 | -2.3 |
| 0.6 | -0.8 | -0.7 | -1.3 | -0.3 | 0.6 | 4.6 | 7.8 | 2.0 | 5.9 | -0.9 | -1.5 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| 3 | 2 | 2 | 2 | 1 | 2 | 4 | 7 | 7 | 10 | 10 | 9 |
Current Liabilities Current LiabilitiesCr | 5 | 6 | 4 | 7 | 6 | 9 | 10 | 10 | 4 | 6 | 3 | 2 |
Non Current Liabilities Non Current LiabilitiesCr | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 3 | 1 | 0 | 0 | 0 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 10 | 11 | 8 | 10 | 9 | 12 | 15 | 17 | 9 | 13 | 9 | 7 |
Non Current Assets Non Current AssetsCr | 2 | 2 | 2 | 2 | 2 | 3 | 5 | 6 | 7 | 7 | 9 | 8 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 0 | 1 | 0 | 1 | 5 | 1 | 3 |
Investing Cash Flow Investing Cash FlowCr | 0 | -1 | -2 | -2 | -1 | -1 | -2 |
Financing Cash Flow Financing Cash FlowCr | 0 | 0 | 2 | 1 | -4 | 0 | -1 |
|
Free Cash Flow Free Cash FlowCr | 0 | 0 | -2 | -1 | 4 | 0 | 3 |
| -229.2 | 351.8 | 14.6 | 32.1 | 576.6 | 32.7 | -892.9 |
CFO To EBITDA CFO To EBITDA% | 53.8 | 100.4 | 9.2 | 19.7 | 218.4 | 18.8 | 1,835.5 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 0 | 0 | 3 | 0 | 0 | 4 | 13 | 17 | 28 | 16 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.2 | 4.2 | 20.4 | 11.9 | 0.0 |
Price To Sales Price To Sales | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | 0.2 | 0.2 | 0.5 | 0.4 |
Price To Book Price To Book | 0.0 | 0.0 | 0.0 | 0.6 | 0.0 | 0.0 | 0.6 | 1.2 | 1.5 | 2.0 | 1.1 |
| 2.7 | 21.5 | 8.4 | 24.2 | 7.1 | 3.6 | 3.3 | 4.0 | 9.4 | 7.8 | 98.7 |
Profitability Ratios Profitability Ratios |
| 15.0 | 14.6 | 18.3 | 16.0 | 18.8 | 26.1 | 31.8 | 24.3 | 22.7 | 28.0 | 26.1 |
| 3.1 | 0.5 | 0.9 | 0.9 | 1.3 | 3.0 | 8.6 | 7.0 | 2.8 | 7.7 | 0.5 |
| 0.8 | -1.3 | -1.1 | -1.9 | -0.3 | 0.9 | 5.4 | 4.3 | 1.1 | 4.4 | -1.0 |
| 8.8 | 0.1 | 0.4 | -5.5 | 2.7 | 8.2 | 20.9 | 26.6 | 11.2 | 20.6 | -1.2 |
| 3.6 | -4.9 | -4.3 | -9.7 | -1.8 | 4.5 | 24.7 | 29.2 | 7.1 | 17.1 | -2.6 |
| 2.0 | -2.5 | -2.6 | -4.4 | -0.9 | 1.7 | 9.4 | 13.3 | 5.0 | 11.7 | -2.1 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Sreechem Resins Limited is a specialized Indian chemical manufacturer with a legacy dating back to **1988**. The company is a prominent player in the **Phenolic Resins** and **Allied Products** sector, primarily serving the refractory units that support the **Indian Steel industry**. With over three decades of operational history, the company is currently navigating a transition from traditional industrial resins toward high-value specialty chemicals and consumer-facing products.
---
### **Manufacturing Footprint & Corporate Structure**
The company operates through a centralized corporate hub and two strategic manufacturing locations situated near key industrial belts:
* **Works I (Registered Office):** Located in Jhagarpur, Rajgangpur, **Odisha**.
* **Works II:** Located in Durramuda, Raigarh, **Chhattisgarh**.
* **Corporate Office:** Netaji Subhash Road, **Kolkata**, West Bengal.
Sreechem Resins operates as a single-segment entity focused on **Resins and Chemicals**. It is exclusively domiciled in India with no foreign subsidiaries, maintaining a lean corporate structure.
---
### **Core Product Portfolio & Market Linkages**
The company’s revenue is derived from the production of phenol-based resins, specialty chemicals, and binders. Its product line is categorized into established industrial brands and emerging consumer goods:
* **Industrial Brands:** Key products include **C-MAX**, **Seelanshield**, **Garmikool**, **UC-555**, and **COC-05**.
* **Application:** These products serve as essential binders for the refractory industry, which is intrinsically linked to the growth and production cycles of the **Indian Steel sector**.
* **Consumer Diversification:** The **R&D Department** is currently developing and commercializing proprietary consumer-facing products. While current sales volumes are **presently very small**, management anticipates these will become a long-term growth driver as market penetration increases.
---
### **Financial Performance & Capital Structure**
Despite a volatile macro environment, the company reported a significant increase in bottom-line performance for the most recent full fiscal year, though quarterly stability remains a challenge.
#### **Key Financial Indicators**
| Metric (₹ in lacs) | FY 2023-24 | FY 2022-23 |
| :--- | :---: | :---: |
| **Net Profit** | **235.21** | **81.63** |
| **Trade Receivables** | **826.41** | **385.76** |
| **Other Financial Assets** | **22.73** | **-** |
| **Dividend Recommended** | **Nil** | **Nil** |
#### **Capital Infusion (May 2024)**
To bolster working capital and support expansion, the company executed a **Preferential Allotment** to the **Promoter Group**:
* **Shares Issued:** **2,00,000** Equity Shares.
* **Issue Price:** **₹43.31** (Face Value **₹10** + Premium **₹33.31**).
* **Post-Issue Paid-up Capital:** **₹4,20,00,000** (**42,00,000** shares).
* **Listing:** The new shares were listed on the **BSE** on **July 8, 2024**.
---
### **Strategic Supply Chain & Related Party Dynamics**
Sreechem Resins relies on a network of related parties for proprietary raw materials and custom-designed binders. These transactions are conducted on **arm’s length principles**.
* **Approved Transaction Limits (FY 2026-27):** Up to **₹30 Crores** for specific partners like **Steel Aids Private Limited**.
* **Key Partners:**
* **Josh Commercial Private Limited:** Sourcing of proprietary custom-designed prepared binders.
* **Nuvi Innochem Private Limited:** Purchase of binders and sale of liquid resins/solvents.
* **FY 2023-24 Volume:** Total related party purchases reached **₹15,00,93,742**, while sales totaled **₹1,35,53,257**.
---
### **Industry Competitive Landscape**
The Indian Phenolic Resin industry is a niche market characterized by high entry barriers and a limited number of players (**5 to 6 established manufacturers**).
* **Import Pressure:** The industry faces significant "dumping" of low-cost refractories and resins from **China**, which has depressed domestic prices and net realizations.
* **New Entrants:** The recent commencement of production by a **new domestic resin producer** has further intensified price competition.
* **Steel Sector Correlation:** While the long-term upswing in Indian Steel is a positive driver, short-term fluctuations in steel demand directly impact Sreechem’s order book.
---
### **Risk Profile & Operational Challenges**
#### **1. Concentration & Demand Risks**
* **Customer Concentration:** While reducing, the risk remains high. A single customer accounted for **33.10%** of revenue in FY25, down from **50.39%** in FY24 and **68.34%** in FY23.
* **Order Volatility:** The company has faced a "gloomy" outlook for its **Coal-based Specialty Products**, receiving **zero fresh orders** in the current financial year following a sales slump that began in **July 2022**.
#### **2. Raw Material & Macroeconomic Risks**
* **Phenol Volatility:** As a crude oil derivative, Phenol prices are highly unstable. Supply is constrained by the limited number of domestic manufacturers and intermittent shutdowns at the **H.O.C.L. Unit**.
* **Currency & Interest Rates:** Depreciation of the **Indian Rupee** has inflated input costs, while **RBI interest rate hikes** have increased finance charges on borrowings.
#### **3. Regulatory & Compliance Gaps**
* **Audit Qualifications:** The company does not provide for gratuity and leave encashment liabilities via actuarial valuation (**Ind AS 19**), leading to qualified audit opinions.
* **Listing Status:** The company is **suspended from the Calcutta Stock Exchange (CSE)** and is classified under the **'Z' category**.
* **Insider Trading Compliance:** A failure to maintain a **Structured Digital Database (SDD)** for UPSI was noted, attributed to software glitches.
---
### **Management Strategy & Future Outlook**
To mitigate current headwinds, leadership has implemented a multi-pronged recovery strategy:
* **Leadership Stability:** **Mr. Binod Sharma (MD)** and **Mr. Vikram Kabra (WTD)** have been re-appointed until **March 2028**. **Mr. Vibhor Sharma (WTD)** is appointed through **March 2029** with a remuneration of **₹48,00,000 per annum**.
* **Cost Rationalization:** Management has initiated austerity measures, including the **retrenchment of staff** and strict inventory controls to offset rising interest costs.
* **Product Innovation:** New products for the iron and steel sector have received formal approval from a **leading Steel manufacturer**. The company is now focused on scaling production to improve margins.
* **Digital Transition:** All share transfers have been moved to a **dematerialised form** to comply with **SEBI** mandates and improve investor transparency.